These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 98586)

  • 1. Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.
    Linscott WD; Ranken R; Triglia RP
    J Immunol; 1978 Aug; 121(2):658-64. PubMed ID: 98586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on rat complement. I. Immune adherence and immune hemolysis activities of rat serum.
    Sakamoto M
    Jpn J Exp Med; 1975 Jun; 45(3):183-9. PubMed ID: 1177359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of conglutinin in a quantitative assay for the presence of cell-bound C3bi and evidence that a single molecule of C3bi is capable of binding conglutinin.
    Brown EJ; Gaither TA; Hammer CH; Hosea SW; Frank MM
    J Immunol; 1982 Feb; 128(2):860-5. PubMed ID: 7033384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    Hong K; Kinoshita T; Kitajima H; Inoue K
    J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific indicator for mouse lymphocyte C3b receptors.
    Linscott WD; Ranken R
    J Immunol; 1978 Jul; 121(1):221-4. PubMed ID: 670699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3.
    Rabellino EM; Ross GD; Polley MJ
    J Immunol; 1978 Mar; 120(3):879-85. PubMed ID: 632590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bovine complement system.
    Linscott WD; Triglia RP
    Adv Exp Med Biol; 1981; 137():413-30. PubMed ID: 7331946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved efficiency of mouse, guinea pig and human C3b inactivator at low ionic strength, and reproducible immune-adherence with mouse complement.
    Linscott WD; Triglia RP
    J Immunol Methods; 1977; 15(2):121-9. PubMed ID: 845446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3-mediated cytoadherence. II. Dependence of cell attachment on similar topographic distribution of the receptors (for C3) and the ligands (C3/C3b).
    Landen B; Strunkheide K; Dierich MP
    J Immunol; 1978 Dec; 121(6):2539-41. PubMed ID: 102696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.
    Koopman WJ; Sandberg AL; Wahl SM; Mergenhagen SE
    J Immunol; 1976 Jul; 117(1):331-6. PubMed ID: 932430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.